Literature DB >> 18658136

Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity.

R Max Wynn1, Masato Kato, Jacinta L Chuang, Shih-Chia Tso, Jun Li, David T Chuang.   

Abstract

Human pyruvate dehydrogenase complex (PDC) is down-regulated by pyruvate dehydrogenase kinase (PDK) isoforms 1-4. PDK4 is overexpressed in skeletal muscle in type 2 diabetes, resulting in impaired glucose utilization. Here we show that human PDK4 has robust core-free basal activity, which is considerably higher than activity levels of other PDK isoforms stimulated by the PDC core. PDK4 binds the L3 lipoyl domain, but its activity is not significantly stimulated by any individual lipoyl domains or the core of PDC. The 2.0-A crystal structures of the PDK4 dimer with bound ADP reveal an open conformation with a wider active-site cleft, compared with that in the closed conformation epitomized by the PDK2-ADP structure. The open conformation in PDK4 shows partially ordered C-terminal cross-tails, in which the conserved DW (Asp(394)-Trp(395)) motif from one subunit anchors to the N-terminal domain of the other subunit. The open conformation fosters a reduced binding affinity for ADP, facilitating the efficient removal of product inhibition by this nucleotide. Alteration or deletion of the DW-motif disrupts the C-terminal cross-tail anchor, resulting in the closed conformation and the nearly complete inactivation of PDK4. Fluorescence quenching and enzyme activity data suggest that compounds AZD7545 and dichloroacetate lock PDK4 in the open and the closed conformational states, respectively. We propose that PDK4 with bound ADP exists in equilibrium between the open and the closed conformations. The favored metastable open conformation is responsible for the robust basal activity of PDK4 in the absence of the PDC core.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658136      PMCID: PMC2533096          DOI: 10.1074/jbc.M802249200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  GHKL, an emergent ATPase/kinase superfamily.

Authors:  R Dutta; M Inouye
Journal:  Trends Biochem Sci       Date:  2000-01       Impact factor: 13.807

2.  (R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase.

Authors:  T D Aicher; R C Anderson; G R Bebernitz; G M Coppola; C F Jewell; D C Knorr; C Liu; D M Sperbeck; L J Brand; R J Strohschein; J Gao; C C Vinluan; S S Shetty; C Dragland; E L Kaplan; D DelGrande; A Islam; X Liu; R J Lozito; W M Maniara; R E Walter; W R Mann
Journal:  J Med Chem       Date:  1999-07-29       Impact factor: 7.446

3.  A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes.

Authors:  L J Reed
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

4.  Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase.

Authors:  C N Steussy; K M Popov; M M Bowker-Kinley; R B Sloan; R A Harris; J A Hamilton
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

5.  Control of pyruvate dehydrogenase kinase gene expression.

Authors:  R A Harris; B Huang; P Wu
Journal:  Adv Enzyme Regul       Date:  2001

6.  Production of recombinant E1 component of branched-chain alpha-keto acid dehydrogenase complex.

Authors:  J W Hawes; Y Zhao; K M Popov; Y Shimomura; R A Harris
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

7.  ESPript: analysis of multiple sequence alignments in PostScript.

Authors:  P Gouet; E Courcelle; D I Stuart; F Métoz
Journal:  Bioinformatics       Date:  1999-04       Impact factor: 6.937

8.  Probing the mechanism of inactivation of human pyruvate dehydrogenase by phosphorylation of three sites.

Authors:  L G Korotchkina; M S Patel
Journal:  J Biol Chem       Date:  2000-11-22       Impact factor: 5.157

9.  Marked differences between two isoforms of human pyruvate dehydrogenase kinase.

Authors:  J C Baker; X Yan; T Peng; S Kasten; T E Roche
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

10.  Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair.

Authors:  C Ban; M Junop; W Yang
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

View more
  34 in total

1.  Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.

Authors:  Shih-Chia Tso; Mingliang Lou; Cheng-Yang Wu; Wen-Jun Gui; Jacinta L Chuang; Lorraine K Morlock; Noelle S Williams; R Max Wynn; Xiangbing Qi; David T Chuang
Journal:  J Med Chem       Date:  2017-01-31       Impact factor: 7.446

2.  A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.

Authors:  Cheng-Yang Wu; Santhosh Satapati; Wenjun Gui; R Max Wynn; Gaurav Sharma; Mingliang Lou; Xiangbing Qi; Shawn C Burgess; Craig Malloy; Chalermchai Khemtong; A Dean Sherry; David T Chuang; Matthew E Merritt
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

3.  A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher.

Authors:  Kathryn M Meurs; Sunshine Lahmers; Bruce W Keene; Stephen N White; Mark A Oyama; Evan Mauceli; Kerstin Lindblad-Toh
Journal:  Hum Genet       Date:  2012-03-25       Impact factor: 4.132

Review 4.  The pyruvate dehydrogenase complexes: structure-based function and regulation.

Authors:  Mulchand S Patel; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

5.  Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.

Authors:  Shih-Chia Tso; Xiangbing Qi; Wen-Jun Gui; Cheng-Yang Wu; Jacinta L Chuang; Ingrid Wernstedt-Asterholm; Lorraine K Morlock; Kyle R Owens; Philipp E Scherer; Noelle S Williams; Uttam K Tambar; R Max Wynn; David T Chuang
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

Review 6.  The metastable states of proteins.

Authors:  Debasish Kumar Ghosh; Akash Ranjan
Journal:  Protein Sci       Date:  2020-04-11       Impact factor: 6.725

7.  Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability.

Authors:  Clair Crewe; Christopher Schafer; Irene Lee; Michael Kinter; Luke I Szweda
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

8.  Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.

Authors:  Jun Li; Masato Kato; David T Chuang
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

9.  Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α-ketoacid dehydrogenase kinase.

Authors:  Shih-Chia Tso; Xiangbing Qi; Wen-Jun Gui; Jacinta L Chuang; Lorraine K Morlock; Amy L Wallace; Kamran Ahmed; Sunil Laxman; Philippe M Campeau; Brendan H Lee; Susan M Hutson; Benjamin P Tu; Noelle S Williams; Uttam K Tambar; R Max Wynn; David T Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

10.  Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.

Authors:  Masato Kato; R Max Wynn; Jacinta L Chuang; Shih-Chia Tso; Mischa Machius; Jun Li; David T Chuang
Journal:  Structure       Date:  2008-12-10       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.